As of 2025-05-18, the Intrinsic Value of Med BioGene Inc (MBI.H.V) is -0.02 CAD. This MBI.H.V valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.02 CAD, the upside of Med BioGene Inc is -259.10%.
Based on its market price of 0.02 CAD and our intrinsic valuation, Med BioGene Inc (MBI.H.V) is overvalued by 259.10%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.02 - -0.02 | -0.02 | -259.10% |
| P/E | 0.01 - 0.01 | 0.01 | -50.7% |
| DDM - Stable | (0.05) - (0.24) | (0.14) | -1048.7% |
| DDM - Multi | (0.05) - (0.20) | (0.08) | -653.8% |
| Market Cap (mil) | 0.23 |
| Beta | 0.52 |
| Outstanding shares (mil) | 15.26 |
| Enterprise Value (mil) | 0.23 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.33% |
| Cost of Debt | 5.00% |
| WACC | 6.00% |